Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-21
2010-11-16
Hui, San-ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07834024
ABSTRACT:
The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.
REFERENCES:
patent: 7060827 (2006-06-01), Singh et al.
patent: 7122542 (2006-10-01), Singh et al.
patent: 7329671 (2008-02-01), Singh et al.
patent: 7329672 (2008-02-01), Singh et al.
patent: 7332484 (2008-02-01), Singh et al.
patent: 7452879 (2008-11-01), Singh et al.
patent: 2004/0029902 (2004-02-01), Singh et al.
patent: 2005/0209230 (2005-09-01), Singh et al.
patent: 2005/0234049 (2005-10-01), Singh et al.
patent: 2006/0058525 (2006-03-01), Singh et al.
patent: 2006/0135543 (2006-06-01), Singh et al.
patent: 2006/0167254 (2006-07-01), Cooper et al.
patent: 2006/0211657 (2006-09-01), Singh et al.
patent: 2006/0234983 (2006-10-01), Singh et al.
patent: 2006/0270694 (2006-11-01), Wong
patent: 2006/0293311 (2006-12-01), Li et al.
patent: 2007/0004626 (2007-01-01), Masuda et al.
patent: 2007/0060603 (2007-03-01), Singh et al.
patent: 2007/0117775 (2007-05-01), Payan
patent: 2007/0129360 (2007-06-01), Phamidipati et al.
patent: 2007/0129362 (2007-06-01), Bhamidipati et al.
patent: 2007/0197782 (2007-08-01), Clough et al.
patent: 2007/0203161 (2007-08-01), Argade et al.
patent: 2007/0203162 (2007-08-01), Li et al.
patent: 2007/0225321 (2007-09-01), Singh et al.
patent: 2007/0225495 (2007-09-01), Singh et al.
patent: 2007/0293520 (2007-12-01), Singh et al.
patent: 2007/0293521 (2007-12-01), Singh et al.
patent: 2007/0293522 (2007-12-01), Singh et al.
patent: 2007/0293523 (2007-12-01), Singh et al.
patent: 2007/0293524 (2007-12-01), Singh et al.
patent: 2007/0299095 (2007-12-01), Singh et al.
patent: 2008/0039622 (2008-02-01), Singh et al.
patent: 2008/0194603 (2008-08-01), Li et al.
patent: 2008/0221089 (2008-09-01), Argade et al.
patent: 2008/0279867 (2008-11-01), Atuegbu et al.
patent: 1 598 343 (2005-11-01), None
patent: WO 01/64655 (2001-09-01), None
patent: WO 03/063794 (2003-08-01), None
patent: WO 2004/014382 (2004-02-01), None
patent: WO 2004/069812 (2004-08-01), None
patent: WO 2004/080980 (2004-09-01), None
patent: WO 2005/013996 (2005-02-01), None
patent: WO 2006/035068 (2006-04-01), None
patent: WO 2006/133426 (2006-12-01), None
patent: WO 2007/027238 (2007-03-01), None
patent: WO 2008/079719 (2008-07-01), None
patent: WO 2008/092049 (2008-07-01), None
Byrn, et al., “Solid State Chemistry of Drugs,” 2nd ed., SSCI, Inc., Chapter 10, p. 232-247, 1999.
van De Waterbeemd H, Smith DA, Beaumont K, and Walker DK, “Property-based design: optimization of drug absorption and pharmacokinetics,” Journal of Medicinal Chemistry, Apr. 2001,44(9), 1313-1333.
Vippagunta SR, Brittain HG, and Grant D J, “Crystalline solids,” Advanced Drug Delivery Reviews, May 2001,48(1), 3-26.
U.S. Appl. No. 11/539,142, filed Oct. 5, 2006, Singh et al.
U.S. Appl. No. 11/539,074, filed Oct. 5, 2006, Singh et al.
U.S. Appl. No. 11/943,506, filed Nov. 20, 2007, Bhamidipati et al.
U.S. Appl. No. 12/028,581, filed Feb. 8, 2008, Argade et al.
U.S. Appl. No. 12/030,031, filed Feb. 12, 2008, Li et al.
U.S. Appl. No. 12/175,441, filed Jul. 17, 2008, Singh et al.
U.S. Appl. No. 12/193,627, filed Aug. 18, 2008, Li et al.
U.S. Appl. No. 12/199,705, filed Aug. 27, 2008, Singh et al.
U.S. Appl. No. 12/268,235, filed Nov. 10, 2008, Singh et al.
U.S. Appl. No. 12/268,218, filed Nov. 10, 2008, Singh et al.
U.S. Appl. No. 12/273,357, filed Nov. 18, 2008, Singh et al.
U.S. Appl. No. 12/260,886, filed Oct. 29, 2008, Cooper et al.
Argade Ankush
Bhamidipati Somasekhar
Carroll David
Clough Jeffrey Wayne
Cooper Robin
Hui San-ming
Rigel Pharmaceuticals Inc.
Weaver Austin Villeneuve & Sampson LLP
Young Travis
Zarek Paul
LandOfFree
Compositions and methods for inhibition of the JAK pathway does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for inhibition of the JAK pathway, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibition of the JAK pathway will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4249893